StockNews.AI
IDBA
StockNews.AI
21 days

IDEX Biometrics ASA: First half 2025 report

1. IDEX reduced op-ex by 52% year-over-year to $5.2 million. 2. Staffing decreased to 30 FTEs, cutting costs by $1.9 million. 3. Convertible bond principal reduced from NOK66.6 million to NOK33.3 million. 4. Q2 2025 revenues were only $0.1 million with a net loss of $2.1 million. 5. Management consolidation aims to strengthen investor relations and cut costs.

5m saved
Insight
Article

FAQ

Why Bearish?

Significant net loss and very low revenue raise concerns about financial viability, similar to past declines.

How important is it?

Cost-cutting measures are positive but overshadowed by high operating losses and low revenue.

Why Short Term?

Immediate cost reductions may not offset ongoing losses, affecting price in the near term.

Related Companies

NOKSNEAAPL
IDEX Biometrics ASA's first half 2025 report is attached to this notice. Recent highlights: Operating expenses excluding Cost of materials and Depreciation in the first six months of 2025 amounted to $5.2 million (excluding restructuring cost) compared to $10.7 million for the same period in 2024, resulting in a cost reduction of 52%, year-over-yearAt the end of the second quarter of 2025 the Company had 30 full-time equivalent staff members, a reduction of 10 full-time equivalents compared to previous quarter, and down from 59 on June 30, 2024. Resulted in a cost reduction in compensation and benefits of $1.9 million, 73%, compared to previous quarter, and a cost reduction of $4.1 million, 72%, year-over-year.Heights convertible bond renegotiated and amended Outstanding principal reduced from approx. NOK66.6 million to approx. NOK50.0 million. In July, further reduced to approx. NOK33.3 million Range of operational improvement initiatives being implemented – target quarterly run rate OPEX from end Q3 2025 in the range of $1.5-1.7 millionOn June 1, 2025 IDEX strengthened its management team further. Kjell-Arne Besseberg started as IDEX Chief Operating Officer based in our offices in OsloOn June 15, 2025 employees, directors and consultants subscribed for 299,381,600 shares, totaling approximately NOK 3.0 million. Further strengthening the alignment of interest within the companyOn June 30, 2025, the CEO Anders Storbråten also assumed the role as CFO after Kristian Flaaten. Consolidating the two roles will reduce cost, increase focus and strengthen IDEX investor relations further Financial results Q2 2025: Revenues of $0.1 million in the quarterOperating expenses were $2.6 million (excluding restructuring cost)Net loss was $2.1 million Cash balance per 30 June 2025 at $1.0 million IDEX Biometrics’ reports and presentations are available on our website: www.idexbiometrics.com/investors For further information, please contact: Anders Storbråten, CEO and CFO, Tel: +47 416 38 582 E-mail: ir@idexbiometrics.com About IDEX Biometrics: IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market. For more information, visit www.idexbiometrics.com About this notice: This notice was issued by Kjell-Arne Besseberg, COO, on 27 August 2025 at 07:00 CEST on behalf of IDEX Biometrics ASA. This information is subject to the disclosure requirements pursuant to the Norwegian Securities Trading Act section 5-12. IDEX 2025 1H report_pub

Related News